CAS 851681-89-5

5H-Furo[2,3-f]indole-7-carboxamide,6,7-dihydro-5-methyl-6-oxo-N-1,3,4-thiadiazol-2-yl-

Description:

5H-Furo[2,3-f]indole-7-carboxamide, 6,7-dihydro-5-methyl-6-oxo-N-1,3,4-thiadiazol-2-yl- is a complex organic compound characterized by its unique fused ring structure, which includes a furoindole framework and a thiadiazole moiety. This compound typically exhibits properties such as moderate solubility in organic solvents and potential bioactivity, making it of interest in medicinal chemistry. The presence of functional groups like carboxamide and thiadiazole suggests it may participate in hydrogen bonding and other intermolecular interactions, which can influence its reactivity and biological activity. Additionally, the methyl and oxo substituents contribute to its chemical stability and may affect its pharmacokinetic properties. Compounds of this nature are often investigated for their potential therapeutic applications, including anti-inflammatory or anticancer activities, due to their structural diversity and ability to interact with biological targets. However, specific characteristics such as melting point, boiling point, and spectral data would require empirical measurement or literature reference for precise values.

Formula: C₁₄H₁₀N₄O₃S

BML-288

CAS: 851681-89-5

BML-288 is a phosphodiesterase Type II (PDE2) inhibitor that demonstrates no inhibition of 5-lipoxygenase (5-LO) or cyclooxygenase (COX-1).

Formula: C₁₄H₁₀N₄O₃S

Color and Shape: Solid

Molecular weight: 314.32

Ref: TM-T68558